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The origin of pyruvate:NADP
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Euglena gracilis, a protist having chloroplasts, has unique
mitochondria, in which the common pyruvate and 2-oxoglu-
trate dehydrogenase multienzyme complexes are absent [1]. In
the mitochondria, 2-oxoglutrate is converted to succinate
through succinate semialdehyde by the sequential reactions
of 2-oxoglutrate decarboxylase and succinate semialdehyde
dehydrogenase. In contrast, pyruvate is oxidized in a CoA-
dependent reaction to form acetyl-CoA and CO2 by the action
of a single enzyme, pyruvate:NADP oxidoreductase (PNO)
(EC 1.2.1.51), with NADP (but not NAD) as an electron
acceptor. It is suggested that these three enzymes participate
in the respiratory metabolism of this organism. PNO, in con-
trast to the other two enzymes, has not yet been found in any
other organisms. These unique characteristics of Euglena pro-
vide insight regarding the origin of mitochondria. In this com-
munication, we propose that PNO was evolved from pyruva-
te:ferredoxin oxidoreductase (PFO) by linking with a
£avoprotein with both FMN and FAD at the C-terminal
side by gene fusion.
To address the origin of PNO, we cloned cDNA encoding
this enzyme and analyzed it. The PNO cDNA (5861 bp) had
an open reading frame encoding a polypeptide with 1803 ami-
no acid residues. The N-terminal amino acid in the mature
form of this enzyme (Thr [1]) was found at the position of 38
in the deduced amino acid sequence of the cDNA. It is thus
indicated that the mature form of PNO, a homodimeric pro-
tein, consists of 1766 amino acid residues per subunit (calcu-
lated subunit molecular weight: 195 536), and the precursor
form of this enzyme has a signal sequence with 37 amino acid
residues for targeting to mitochondria.
We have reported that limited proteolysis of PNO with
trypsin gives two functionally active fragments [1]. One of
the two fragments, derived from the N-terminal side of this
enzyme, retains a homodimeric structure, and is still capable
of catalyzing the CoA-dependent oxidative decarboxylation of
pyruvate when an arti¢cial electron acceptor, such as methyl
viologen, is substituted for NADP. Another fragment (the
C-terminal fragment) is a monomeric peptide and retains an
electron-transfer activity from NADPH to methyl viologen or
other arti¢cial electron acceptors. In the deduced amino acid
sequence of the PNO cDNA, the N-terminal amino acid of
the C-terminal fragment (Ala [1]) was found at the position of
1240. The amino acid sequence of the N-terminal fragment of
PNO (amino acid position in the deduced amino acid se-
quence of the cDNA: 38^1239) closely resembled the sequen-
ces of homodimeric PFOs found in amitochondriate eukary-
ote Entamoeba histolytica (53% positional identity) and
Trichomonas vaginalis (44%), and in eubacterium Rhodospiril-
lum rubrum (44%), Klebsiella pneumoniae (49%) and Desulfo-
vibrio africanus (53%). Similar to these homodimeric PFORs
[2], this result shows that the N-terminal part of PNOR likely
contains in each subunit one TBP, two ferredoxin-type [4Fe^
4S] clusters, and one [4Fe^4S] cluster bound to an atypical
cysteine-containing sequence motif. In contrast, the C-termi-
nal fragment of PNO (amino acid position: 1240^1803)
showed structural similarity to mammalian NADPH-cyto-
chrome P450 reductase (positional identity to rat enzyme:
28%) and to bacterium NADPH-sul¢te reductase K subunit
(positional identity to Salmonella typhimurium enzyme: 21%).
This ¢nding suggests that the C-terminal part of PNOR, as
well as NADPH-cytochrome P450 reductase and NADPH-
sul¢te reductase K subunit [3], has FMN and FAD (each
one per subunit).
It is thus suggested that each subunit (about 195 kDa) of
PNO, a homodimeric protein, consists of two functional com-
ponents, Fe^S domain (about 130 kDa) and £avodomain
(about 65 kDa); the Fe^S domain locates at the N-terminal
side and is linked with the £avodomain by a trypsin-sensitive
hinge region (Fig. 1). The reaction mechanism of this enzyme
is thought as follows: On the Fe^S domain, pyruvate is oxi-
dized in a CoA-dependent reaction to form acetyl-CoA and
CO2 by the cooperation of TBP and [4Fe^4S] clusters. Two
electrons formed by the pyruvate oxidation in the Fe^S do-
main are once transferred to the £avodomain with FMN and
FAD as redox centers, then accepted by NADP.
In archaea, most anaerobic eubacteria and amitochondriate
eukaryotes, PFO acts for the oxidative decarboxylation of
pyruvate to form acetyl-CoA, and the two electrons formed
are accepted by ferredoxin with a more negative redox poten-
tial than that of NAD [2]. This is in contrast to most respi-
ratory organisms having the pyruvate dehydrogenase multi-
enzyme complex. On the basis of subunit structure, PFOs are
divided into homodimeric, heterodimeric and heterotetrameric
types. These three types of PFO are phylogenetically close and
their evolution is explained by the rearrangement and eventual
fusion of four ancestral genes. Amitochondriate eukaryotes
have homodimeric PFO, and this enzyme plays a central
role in anaerobic energy metabolism [4,5]. In particular, in
amitochondriate eukaryotes having hydrogenosomes (the
double-membrane-bound, H2- and ATP-producing organ-
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Fig. 1. A structural model and proposed reaction mechanism of
PNO. 6Trypsin: trypsin-sensitive hinge region; NH2 : N-terminal;
COOH: C-terminal.
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elles), such as Trichomonas, PFO is located in the organelles
and participates, together with hydrogenase, in the formation
of acetate and H2 from pyruvate, yielding ATP by substrate-
level phosphorylation.
On the basis of this evidence, we propose that PNO was
evolved by linking with a homodimeric PFO and a £avoen-
zyme (which is the same origin as NADPH-cytochrome P450
reductase and NADPH-sul¢te reductase K subunit) by gene
fusion. In other words, the ferredoxin-type enzyme was con-
verted to the NADP-dependent one by linking covalently
with a £avoprotein with both FMN and FAD at the C-ter-
minal side. In addition, it is thought that this conversion was
necessary to make it possible to participate in the respiratory
metabolism in the mitochondria of E. gracilis. In the hydro-
gen hypothesis for the ¢rst eukaryote, mitochondria and hy-
drogenosomes are proposed to originate from a common an-
cestor [5]. Thus, the occurrence of PNO in Euglena
mitochondria is interesting in understanding the relationship
between mitochondria and hydrogenosomes.
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Disul¢de bridges of Ergtoxin,
a member of a new sub-family
of peptide blockers of the
ether-a-go-go-related K channel
C. Bottiglieria, L. Ferraraa, M. Coronab, G.B. Gurrolab,
C. Batistab, E. Wankec, L.D. Possanib;*
A new class of peptides named Ergtoxin (ErgTx), which
block ERG-K-channels of nerve, heart and endocrine cells,
was isolated from the venom of the Mexican scorpion Cen-
truroides noxius [1]. Because ErgTx showed a signi¢cantly dif-
ferent amino acid sequence from those of previously reported
K-channel speci¢c scorpion toxins [2], it was important to
determine the disul¢de bridges and compare it with the others.
Due to the presence of two cysteines in immediate vicinity
(positions 23 and 24) it was not possible to determine its
disul¢de pairing using classical biochemical methods, and a
thorough analysis by mass spectrometry was performed [3,4].
During this procedure, we discovered that two amino acid
residues of the peptide used for our experiments [1] were
not the same. There is an extra disul¢de bridge and conse-
quently two of the previous reported residues (a glutamine
and a proline residue) are in fact cysteines. These results
were obtained by direct sequencing, mass spectrometry anal-
ysis of native versus alkylated toxin and further con¢rmed by
cloning the gene that encodes ErgTx (forthcoming).
In fact, the ErgTx published by Gurrola et al. [1], with the
amino acid sequence: DRDSCVDKSRCAKYGYYQECQD-
CCKNAGHNGGTQMFFKCKAP, does not correspond to
the physiological functions described. The amino acid se-
quence of the new isoform, reported here, is the one used
for the experiments previously reported [1], whose amino
acid sequence is: DRDSCVDKSRCAKYGYYQECQDCCK-
NAGHNGGTCMFFKCKCA (GenBank accession number
CnErg1). This sequence was obtained by direct Edman deg-
radation using a Beckman LF3000 Protein sequencer instru-
ment, which allowed unequivocal identi¢cation of the ¢rst
41 amino acid residues. The alanine in position 42 was con-
¢rmed by mass spectrometry analysis, after carboxypeptidase-
Y hydrolysis of reduced and alkylated toxin with iodoacet-
amide, following a method previously described [5]. The mo-
lecular mass of this new ErgTx is 4730.8 þ 0.4 Da (theoretical
value 4730.4 Da), which after reduction and alkylation gave
the mass of 5195 Da (compatible with the presence of eight
Fig. 1. MALDI-MS analysis of ErgTx digests. Native protein was
digested with trypsin (A) followed by endopeptidase AspN (B). Sig-
nals corresponding to the disul¢de-bridged peptides are indicated;
each signal is assigned to the corresponding peptide pair.
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cysteines), hence con¢rming unequivocally the presence of
four disul¢de bridges in the native ErgTx. The published se-
quence (¢rst one listed above) is thought to be another iso-
form, which is now under investigation. This apparent con-
fusion came from the usage of di¡erent chromatographic
procedures to obtain peptides active on ERG-channels (paper
in preparation, to be published elsewhere). All the physiolog-
ical work performed and included in our initial reference [1]
was done with the same batch of peptide, and the same sam-
ple was used for sequencing and disul¢de bridge determina-
tion reported here.
Native toxin was digested with trypsin at pH 6.3 in order to
avoid scrambling phenomena and the resulting peptide mix-
ture was directly loaded, either in a MALDI-TOF DE-PRO
(PerSeptive Biosystems) or in a Platform single quadrupole
mass spectrometer (Micromass) and analyzed [3,4]. The spec-
tra obtained are shown in Fig. 1. In addition to ErgTx, four
clear signals were assigned to S^S bridged peptides on the
basis of their unique mass values and their disappearance
following incubation with dithiothreitol. The signal at m/z
1703.0 was interpreted as arising from peptides (11^13) and
(26^38) linked by a disul¢de bond between Cys-11 and Cys-
34; its satellite peak at m/z 1718.8 was associated to the same
peptide presenting Met-35 in oxidized form. Finally, the in-
tense MH signals at m/z 2858.2 and 2876.4 were associated
to a three- and four-peptide clusters involving fragments
(1^8)+(14^25)+(39^42) and (1^8)+(14^25)+(39^40)+(41^42)
respectively, linked by three disul¢de bonds between Cys-5,
Cys-20, Cys-23, Cys-24, Cys-39 and Cys-41. These ¢ndings
were con¢rmed by MALDI-MS analysis of the entire digest
following treatment with carboxypeptidase B and/or sequence
analysis of the corresponding peptide fractions obtained from
HPLC puri¢cation. The assignment of other cysteine pairings
was obtained by a consecutive digestion of this digest with
endopeptidase AspN. In addition to the signal associated to
the peptide (11^13)+(26^38) (not containing Asp residues), the
spectrum showed ¢ve clear peaks at m/z 1301.5, 1321.9,
2343.6, 2361.9 and 2379.7. All signals disappeared following
addition of dithiothreitol. The former was interpreted as aris-
ing from peptides (14^21)+(39,40) linked by a disul¢de bridge
between Cys-20 and Cys-39. The second one was assigned to
its complementary three-peptide cluster involving fragments
(3^8), (22^25) and (41^42) linked by the two possible disul¢de
bonds Cys5^Cys23 and Cys24^Cys41 or Cys5^Cys24 and
Cys23^Cys41. On the basis of the sequence homology, sec-
ondary element conservation and the identical arrangement
of two of the four disul¢des with respect to other known
toxins [2], we concluded that the cysteine pairing in this new
ErgTx isoform is Cys5^Cys23, Cys11^Cys34, Cys20^Cys39
and Cys24^Cys41. Therefore, the remaining signals in the
spectrum were associated to the three-, four- and ¢ve-
peptide clusters involving fragments (3^6)+(14^25)+(39^42),
(3^6)+(14^21)+(22^25)+(39^42) and (3^6)+(14^21)+(22^25)+
(39^40)+(41,42) respectively, linked by the disul¢de bonds
Cys5^Cys23, Cys20^Cys39 and Cys24^Cys41.
Thus, the disul¢de bridges of ErgTx are formed between
cysteines: Cys5^Cys23, Cys11^Cys34, Cys20^Cys24 and
Cys23^Cys41.
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